Why Most Cosmetics Brands Can't Create a Category: 3 Regulatory Walls Hiding in Plain Sight

On a long enough timeline, every marketer becomes their own narrator.

You have a great product. Every claim that would create a category is the same claim a federal statute can break. Here are the three statutes, and the architecture that survives all of them.

The Problem: You're Trying To Carve A Category. The Regulator Reads Your Label.

Here's the pain. You spent two years on the formula. The story is clean. You wrote a paragraph about what makes the product new, and your lawyer cut most of it. Your agency rewrote the rest as something so vague no buyer remembers a single phrase. Every quarter you stay on that page, you pay brand spend for copy the market forgets by Friday. The product on the shelf next to yours runs the same vague language. The reader can't tell you apart. They open the same generic website, they read the same vague hero copy, and they buy whoever ships faster.

That's the external problem. The internal one is worse.

You feel like the system is built against new players. The big brands seem to claim more, not less. Their lawyers are bigger, their advertising runs louder, and they hit the shelves first. You assume the rules are different for them, or that you missed a meeting where someone signed off on how this works.

I thought the same thing for a long time. Then I read the statutes. The problem isn't a writing problem. It's structural. I'd spent years writing around it. The right move was to build with it.

Category creation in tech or DTC means inventing a new outcome and owning the word for it. Category creation in cosmetics means something else. Three federal statutes have already decided which outcome words you may use, when you may use them, and what you must prove first. The playbook the marketing books wrote for you was built for an unregulated category. Cosmetics has not been unregulated in the United States since 1938.

The Guide: Three Walls You Have Been Bouncing Off

Most cosmetics brands launch. A handful build categories. The gap between the two groups is rarely the formula. It's the relationship the founder builds to these three walls. The brands I read about all hit these walls. The brands that scaled past them built a different shape.

Wall 1. FDA structure-function language under §201(g).

According to the FDA's own published guidance on what counts as a cosmetic versus a drug, the Food, Drug, and Cosmetic Act defines a "drug" to include any article intended to affect the structure or any function of the human body¹. The moment a cosmetic claims an effect on what the body does (regenerating, lifting, plumping, restoring, healing), the product can be reclassified as a drug. A drug requires a New Drug Application. New Drug Applications run into the hundreds of millions in cost and roughly a decade in clinical trials. Your serum is now a drug. You did not file. The label gets pulled. You sign the recall order. You ship the inventory back at your cost.

Wall 2. MoCRA: the new floor for every cosmetics brand.

According to the law itself, the Modernization of Cosmetics Regulation Act of 2022 was signed into Public Law on December 29, 2022². Every cosmetics facility had until July 1, 2024 to register with FDA and list every product on the shelf. You file adverse event reports the day they hit your inbox. Safety substantiation records must sit on file and ship to FDA on request. The cost of being a cosmetics brand went up. The cost of being a careless one went up more.

Wall 3. FTC substantiation under Section 5.

According to the Federal Trade Commission's enforcement record, every health or efficacy claim requires "competent and reliable scientific evidence" before the claim is made. In FTC v. Teami LLC, March 2020 (Case 8:20-cv-00518), the FTC charged a tea brand whose paid influencers claimed detoxification and disease prevention. The case closed on a multi-million dollar judgment suspended on inability-to-pay grounds³. In Operation CBDeceit, December 17, 2020, the FTC charged six CBD sellers and closed each one with civil penalties in five figures plus 20-year monitoring orders⁴. The substantiation file precedes the marketing. Not the other way.

The failure mode. Founders try to define a category by inventing a new outcome claim. Each new outcome verb trips one of the three walls. So they retreat to puffery, and puffery defines no category. Both ends fail. The middle (the way through) looks different from either.

The brands that broke through did not try to claim a new outcome. They built the category around a named system.

The Plan: Build A Named System, Not A Better Adjective

Three moves, in this order. Open the brand book, read the regulations, and ship the system rather than the verb.

1. Replace every outcome verb with a system noun.

"Anti-aging serum" is an outcome verb pretending to be a noun. The FDA reads it as a structure-function claim. The FTC reads it as a substantiation claim. The buyer reads it as the same line every competitor runs.

Olaplex did not sell a "stronger hair serum." Olaplex sold a "bond multiplier" built on a patented chemistry (bis-aminopropyl diglycol dimaleate). According to the company's own filings, Olaplex opened on NASDAQ as OLPX in September 2021⁵. The label describes a structural action, not an outcome the buyer might claim. The buyer writes the outcome talk in the reviews.

Drunk Elephant did not sell "younger-looking skin." Drunk Elephant sold the "Suspicious 6": a named list of six ingredient classes (essential oils, drying alcohols, silicones, chemical sunscreens, fragrances, SLS) the brand refuses to ship in any formula. According to Shiseido's press release, Shiseido bought the brand for roughly $845 million in October 2019⁶. The category claim sits in absence. Absence is structure-function compliant by definition.

The Ordinary did not sell "fewer wrinkles." The Ordinary sold ten-percent niacinamide and twenty-percent vitamin C at chemist-grade pricing. According to The Estée Lauder Companies' press releases, Estée Lauder bought into Deciem at a multi-billion-dollar valuation in February 2021, then closed on the rest of the company in June 2024⁷. The structural noun is the active ingredient at the active concentration. The outcome lives in the customer's review.

2. Substantiate the mechanism BEFORE you write the copy.

In all three brands, the mechanism is documented before the brand promises anything. Olaplex filed a patent. Drunk Elephant built a public ingredient policy with peer-reviewed citations behind each banned class. The Ordinary ships third-party assays for every active. The substantiation file is not the compliance team's problem. The file is the marketing department's source material.

This inverts the usual order. The agency wants to write copy and ship it to legal. The right order is to build the file first, then write only the lines the file already supports. Every line you cannot back becomes a line you do not ship.

3. Distribute the outcome through customer voices, not your label.

You cannot say "my serum makes you look five years younger." Your customer can. UGC, reviews, and before-and-afters posted by users are not your label. They are not your advertising. They are user speech.

Build a review-first launch. Send sampling kits at scale before the SKU lists. Read every review the panel writes back. Pull the strongest lines and ship them into your culture page (yes, even into your About page), not into your claims layer. The category memory forms in the customer's mouth. The brand's job is to be quotable, not aspirational. Your label is structural. Your customer writes the marketing.

The Stakes: A Category You Can Lose In A Single Letter

A warning letter does not carry a direct fine (it's a notice, not a penalty), but it carries a record. The record is searchable. Buyers, retailers, and the FTC's next case file all read it. A recall can run six and seven figures fast.

The deeper cost is the category itself. If you scale a claim that triggers a warning letter, you don't just pull the label. You poison the word. You spent two years and the early part of your budget teaching the market a verb the regulator won't let you use. You can't say it again. The new entrants can. They watched you build the runway, get cleared for takeoff, then taxi onto a closed field. The cost of getting this wrong isn't the fine. It's the category position you built into the market, then lost when the letter dropped.

The Call

Open your brand book. Open every label, every page of the site, every paid headline. Make a list. Pull the outcome verb out of each one. Write the structural noun beside it. Cut what your substantiation file can't back, and read the page through again. If the file is empty, build the substantiation file before the next campaign launches. Then write only what the file already proves.

Tomorrow will be the most beautiful day of Raymond K. Hessel's life. His breakfast will taste better than any meal you and I have ever tasted.